Results 121 to 130 of about 36,695 (249)

Current primary open-angle glaucoma treatments and future directions

open access: yes, 2012
Gabriel Beidoe, Shaker A MousaPharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USAAbstract: Primary open-angle glaucoma (POAG) is a leading cause of blindness with no known cure.
Mousa SA, Beidoe G
core  

Evaluation of Factors Influencing the Outcomes of Selective Laser Trabeculoplasty in Primary Open-Angle Glaucom

open access: yes, 2011
Pur po se: To determine demographic and clinical factors that affect the outcomes of selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG).
Çiğdem Altan   +6 more
core   +1 more source

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

Statistical and clinical aspects of glaucoma in the North of the Republic of Moldova [PDF]

open access: yes, 2014
Ophthalmology Department, State Medical and Pharmaceutical University “Nicolae Testemiţanu”, Chişinău, Republic of MoldovaIntroduction: Glaucoma is a group of eye conditions resulting in optic nerve damage, which may cause loss of vision. It is one of
Tumuruc, Irina
core  

Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles

open access: yesMedComm, Volume 7, Issue 6, June 2026.
This article systematically summarized the specific mechanism of aging‐related diseases caused by mitochondrial dysfunction, and summarized the broad‐spectrum treatment methods and disease targeted treatment strategies for mitochondria. At the same time, it also pointed out the dilemma faced by mitochondrial targeted treatment.
Zijie Xiang   +12 more
wiley   +1 more source

Multivariate Regression for Primary Open Angle Glaucoma.

open access: yes, 2016
Multivariate Regression for Primary Open Angle Glaucoma.
Pritha Roy (2575369)   +5 more
core   +1 more source

The evolving role of structural biology in pharma: integration of X‐ray crystallography, cryo‐electron microscopy and beyond

open access: yesActa Crystallographica Section D, Volume 82, Issue 6, Page 587-602, June 2026.
This review describes how an integrated structural biology platform at Merck Sharp & Dohme LLC, Rahway, New Jersey, USA, combining X‐ray crystallography, cryo‐EM, MicroED and cryo‐ET, enables seamless three‐dimensional insights from molecular to cellular length scales.
Jill E. Chrencik   +44 more
wiley   +1 more source

Analysis of Factors that Determine the Degree of Iatrogenic Impact of Surgery on the Ocular Surface in Glaucoma

open access: yesOkulistyka
Introduction Primary open-angle glaucoma is a multifactorial chronic neurodegenerative disease. Although the pathogenesis of glaucoma is not fully understood, it is known that the level of intraocular pressure is interconnected with the death of retinal ...
Iryna Shargorodska   +4 more
doaj   +1 more source

Primary open-angle glaucoma

open access: yesInternational Health Sciences Review
Primary open-angle glaucoma (POAG) is a chronic and progressive optic neuropathy characterized by the degeneration of optic nerve fibers and gradual loss of the visual field. It is the most common form of glaucoma and one of the leading causes of irreversible blindness worldwide.
Sarah Kellen Pereira Prates   +5 more
openaire   +1 more source

Anterior chamber flare and central macular thickness after trabeculectomy versus after phacoemulsification

open access: yesActa Ophthalmologica, Volume 104, Issue 4, Page 402-409, June 2026.
Abstract Purpose To compare the inflammatory response in the eye after trabeculectomy to after phacoemulsification, focusing on anterior chamber flare (AC flare) and central macular thickness (CMT). Methods Data from 436 participants in two randomized controlled trials were analysed.
Yasmeen Ahmed   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy